Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Clinical trial NCT02867020 · COMPLETED
Trial details
- NCT number
- NCT02867020
- Sponsor
- Latin American Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2019-10-09
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.